TWI548873B - Method for quick evaluating neural function by establishing analysis module - Google Patents

Method for quick evaluating neural function by establishing analysis module Download PDF

Info

Publication number
TWI548873B
TWI548873B TW103133108A TW103133108A TWI548873B TW I548873 B TWI548873 B TW I548873B TW 103133108 A TW103133108 A TW 103133108A TW 103133108 A TW103133108 A TW 103133108A TW I548873 B TWI548873 B TW I548873B
Authority
TW
Taiwan
Prior art keywords
nerve
cells
medium
cell
cultured
Prior art date
Application number
TW103133108A
Other languages
Chinese (zh)
Other versions
TW201612523A (en
Inventor
沈孟儒
張廉筠
孫苑庭
張俊彥
Original Assignee
國立成功大學
國立成功大學醫學院附設醫院
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 國立成功大學, 國立成功大學醫學院附設醫院 filed Critical 國立成功大學
Priority to TW103133108A priority Critical patent/TWI548873B/en
Publication of TW201612523A publication Critical patent/TW201612523A/en
Application granted granted Critical
Publication of TWI548873B publication Critical patent/TWI548873B/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Description

建立分析模組快速評估神經功能之方法 Establishing an analysis module to quickly evaluate neural function

本發明係有關於一種建立分析模組快速評估神經功能之方法,尤其係指一套可快速且具代表性分析神經生長功能之方法,包括使用足以代表神經生長的重要標記,搭配最佳化的影像分析流程與程式指令;據此,本方法不僅可快速評估早期神經生長與神經網絡形成的情形,亦可作為篩選藥物之平台,以快速檢測藥物對神經功能的影響。 The present invention relates to a method for establishing an analysis module for rapid assessment of neural function, in particular to a method for rapidly and representatively analyzing nerve growth function, including using an important marker sufficient for representing nerve growth, and optimizing with The image analysis process and program instructions; according to this, the method can not only quickly evaluate the early nerve growth and neural network formation, but also serve as a platform for screening drugs to quickly detect the effects of drugs on nerve function.

隨著癌症治療的進步,病患的存活率得以逐漸提升,由於病患的餘命延長,使得化療藥物的副作用受到重視,尤其化療藥物副作用中,神經病變(neuropathy)對於生活品質影響最大。因此,在接受化療藥物之前,如何有效測試或篩選藥物對遭受化療的神經細胞是否具有毒殺性(neurotoxicity),已成為相關領域研發重點。 With the advancement of cancer treatment, the survival rate of patients has gradually increased. Due to the prolonged life of patients, the side effects of chemotherapy drugs have been paid attention to. Especially in the side effects of chemotherapy drugs, neuropathy (neuropathy) has the greatest impact on quality of life. Therefore, before receiving chemotherapy drugs, how to effectively test or screen drugs for neurotoxicity of nerve cells suffering from chemotherapy has become a research and development focus in related fields.

在檢測藥物是否具有細胞毒性的方法中,常會搭配使用高涵量分析(high-content analysis,HCA)以了解藥物對於細胞型態的影響為何。高涵量分析技術已廣泛地被使用於生技領域如癌症、免疫、心血管和神經研究,並且搭配高通量分析(High-throughput screening)自動化取得多孔盤內細胞螢光影像和影像分析功能,使得實驗得以大規模及快速的進行,並 可提供多種定量資訊。然,目前使用分子標記搭配高通量分析以檢測神經功能的方法尚存在許多問題;舉例而言,Huang Y等人揭示一種體外高涵量神經元篩選(high content neuron-based screening)以探討神經細胞型態的計算架構,其係採用神經元類型Ⅲ β-微管蛋白(TUJ1)為分子標記以研究神經元的機制(J Neurosci Methods.2010 Jul 15;190(2):299-309);Harrill JA等人揭示一種利用高涵量影像分析來檢測化學物對於原代大鼠皮層神經細胞軸樹突生長情形的影響,其係利用微管蛋白(β tubulin)染色區域(全部)扣除微管相關蛋白2(MAP2)染色區域(樹突)之後,剩下的區域代表軸突之方式,分析神經細胞的生長情形(Neurotoxicology.2013 Jan;34:61-73);Nieland TJ等人則利用MAP2、突觸後密度蛋白95-突觸蛋白1(Psd95-Syn1),以及突觸後蛋白-突觸蛋白1(Gphn-Syn1)鑑定神經突觸生成情形(PLoS One.2014 Mar 14;9(3):e91744);上述之方法僅藉由神經細胞軸樹突生長(outgrowth)或突觸生成(synaptogenesis)單一方式,無法全面地判定神經功能好壞;若同時觀察神經細胞的軸、樹突生長以及突觸生成,則需使用多種分子標記,因此過程相當繁瑣且耗時。 In methods for detecting whether a drug is cytotoxic, high-content analysis (HCA) is often used in conjunction with high-content analysis (HCA) to understand the effect of the drug on cell type. High-density analysis techniques have been widely used in biotechnology fields such as cancer, immunology, cardiovascular and neurological research, and with high-throughput screening to automate cellular fluorescence imaging and image analysis in porous discs. The experiment was carried out on a large scale and quickly, and a variety of quantitative information was available. However, there are still many problems in using molecular markers with high-throughput analysis to detect neural function; for example, Huang Y et al. revealed a high content neuron-based screening to explore neural cell types. State of computational architecture, which uses neuronal type III β-tubulin (TUJ1) as a molecular marker to study neuronal mechanisms (J Neurosci Methods. 2010 Jul 15;190(2):299-309); Harrill JA A high-intensity image analysis was used to detect the effect of chemicals on the growth of primary dendritic neurons in primary rat cortical neurons. The cells were stained with tubulin (β III tubulin) (all) to deduct microtubule-associated protein 2 After (MAP2) staining area (dendritic), the remaining area represents the way of axon, analyzing the growth of nerve cells (Neurotoxicology. 2013 Jan; 34: 61-73); Nieland TJ et al. using MAP2, synapse Post-density protein 95-synaptic protein 1 (Psd95-Syn1), and postsynaptic protein-synaptic protein 1 (Gphn-Syn1) identify synaptic production (PLoS One.2014 Mar 14;9(3):e91744 ); the above method is only By a single way of neuronal axis outgrowth or synaptogenesis, it is impossible to comprehensively determine the nerve function; if you observe the axis, dendritic growth and synapse formation of nerve cells at the same time, you need to use a variety of Molecular markers, so the process is quite cumbersome and time consuming.

再者,使用何種神經細胞進行藥物測試,也會影響分析程序及時間;例如使用商品化的神經細胞株雖然較好培養,但為了刺激神經細胞分化,必需額外添加藥物刺激,因此可能影響待測藥物的作用。反觀初代培養細胞(Primary culture cells)可自然分化,故使用初代培養細胞可解決額外添加藥物之問題,但相較於使用細胞株,初代細胞培養較不容易,且如何取得最佳的分化時間點以進行藥物測試,仍須進一步探討。 Furthermore, which kind of nerve cells are used for drug testing will also affect the analysis procedure and time; for example, although commercialized neural cell strains are better cultured, in order to stimulate nerve cell differentiation, additional drug stimulation is necessary, which may affect Test the role of the drug. In contrast, primary culture cells can be naturally differentiated, so the use of primary cultured cells can solve the problem of additional drugs, but compared with the use of cell lines, primary cell culture is not easy, and how to achieve the best differentiation time For drug testing, further investigation is needed.

因此,若能篩選出幾個具代表性的分子標記,並發展一套完 整的功能評估系統,做為評估早期神經生長與神經網絡形成的標的,在省時與完整評估之間取得良好平衡,將可快速、大量及準確地評估神經細胞存活狀況及偵測神經功能的變化。 Therefore, if you can screen out several representative molecular markers, and develop a set of The integrated functional assessment system, as a benchmark for assessing early nerve growth and neural network formation, provides a good balance between time-saving and complete assessment, and will quickly, massively and accurately assess neuronal survival and detect neurological function. Variety.

今,發明人即是鑑於現有評估神經功能變化之方法於實際實施使用時仍具有多處缺失,於是乃藉由其豐富專業知識及多年之實務經驗所輔佐,而加以改善,並據此研創出本發明。 Nowadays, the inventor has made many improvements in the actual implementation of the method for assessing changes in neurological function. Therefore, it has been improved by its rich professional knowledge and years of practical experience, and has been developed accordingly. this invention.

本發明主要目的為提供一種建立分析模組快速評估神經功能之方法,其係指一套快速且具代表性分析神經生長功能之方法,包括使用足以代表神經生長的重要標記,搭配最佳化的影像分析流程與程式;據此,本方法亦可進一步用作篩選藥物之平台,以快速檢測藥物對神經細胞是否具有保護或毒殺作用。 The main object of the present invention is to provide a method for establishing an analysis module for rapid assessment of neural function, which is a rapid and representative method for analyzing nerve growth function, including using an important marker sufficient for representing nerve growth, and optimizing with The image analysis process and program; accordingly, the method can be further used as a platform for screening drugs to quickly detect whether the drug has protective or toxic effects on nerve cells.

為了達到上述實施目的,本發明一種建立分析模組快速評估神經功能之方法,其包括步驟一:利用一螢光顯微影像系統擷取一具有複數個螢光標定(包含Hoechst染劑以標記細胞核)之培養細胞以進行影像分析,其中培養細胞係包含神經細胞;步驟二:依據細胞核之面積大小與螢光強弱,選取表現軸、樹突螢光標定的神經細胞,排除非神經細胞,並計算神經細胞體之面積大小,及軸突、樹突之長度與分支數目,以確認神經細胞之軸、樹突生長情形,其中軸、樹突螢光標定可選自微管相關蛋白2(MAP2)抗體或神經元類型Ⅲ β-微管蛋白(TUJ1),而突觸螢光標定係選自突觸蛋白(Synaptophysin)抗體或突觸後密度蛋白95(PSD95);以及步驟三:根據步驟二之軸、樹突螢光標定範圍,計算神經細胞上突觸(synapse)螢光標定的 數目,以確認神經細胞生長情形,藉以評估神經功能。 In order to achieve the above-mentioned implementation object, the present invention provides a method for rapidly analyzing a nerve function by analyzing a module, which comprises the first step: using a fluorescence microscopic image system to capture a plurality of fluorescing cursors (including Hoechst dye to mark the nucleus) The cultured cells are subjected to image analysis, wherein the cultured cell line comprises nerve cells; Step 2: according to the size of the nucleus and the intensity of the fluorescence, the nerve cells of the expression axis and the dendritic cursor are selected, the non-neuronal cells are excluded, and the calculation is performed. The size of the nerve cell body, and the length of axons, dendrites and the number of branches, to confirm the axis of the nerve cells, dendritic growth, wherein the axis, dendritic cursor can be selected from microtubule-associated protein 2 (MAP2) Antibody or neuronal type III β-tubulin (TUJ1), while synaptic globose cursor is selected from Synaptophysin antibody or postsynaptic density protein 95 (PSD95); and step three: according to step two Axis, dendritic firefly cursor to determine the range, calculate the synapse on the nerve cells (synapse) The number is used to confirm the growth of nerve cells to evaluate nerve function.

於本發明之一實施例中,培養細胞係由下列步驟製得,步驟一:取一出生後0~1天的幼鼠大腦皮質組織,加入一第一培養基(可例如為不含血清之DMEM/F12培養基)打散大腦皮質組織,以形成一混合液;步驟二:過濾混合液,並以離心方式獲得一細胞沉澱液;以及步驟三:將細胞沉澱液培養於一第二培養基內9~12天(最佳為10天),以製備出培養細胞;其中,第二培養基係包含Neurobasal® A培養基(Neurobasal® A medium)、L-麩醯胺酸(L-glutamin)、B-27®添加劑(B-27® Supplement),以及青黴素-鏈黴素(Penicillin/Streptomycin)。 In one embodiment of the present invention, the cultured cell line is prepared by the following steps: Step 1: Take a cerebral cortex tissue of a young mouse from 0 to 1 day after birth, and add a first medium (for example, serum-free DMEM) /F12 medium) to break up the cerebral cortex tissue to form a mixed solution; Step 2: Filter the mixture and obtain a cell pellet by centrifugation; and Step 3: Culture the cell pellet in a second medium 9~ 12 days (preferably 10 days) to prepare cultured cells; wherein the second medium contains Neurobasal ® A medium (Neurobasal ® A medium), L-glutamin, B-27 ® Additive (B-27 ® Supplement), and penicillin-streptomycin.

(S1)‧‧‧步驟一 (S1)‧‧‧Step one

(S2)‧‧‧步驟二 (S2)‧‧‧Step 2

(S3)‧‧‧步驟三 (S3) ‧ ‧ Step 3

第一圖:本發明建立分析模組快速評估神經功能之方法之步驟流程圖 The first figure: the flow chart of the steps of the method for quickly analyzing the neural function of the analysis module of the present invention

第二圖:神經細胞示意圖 Figure 2: Schematic diagram of nerve cells

第三圖:不同培養天數之神經細胞代表圖 Figure 3: Representative representation of nerve cells in different culture days

第四圖:不同培養天數對於神經細胞數量之影響 Figure 4: Effect of different culture days on the number of nerve cells

第五圖:不同培養天數對於神經細胞生長情形之影響 Figure 5: Effect of different culture days on the growth of nerve cells

第六圖:不同培養天數對於突觸數量之影響 Figure 6: Effect of different culture days on the number of synapses

第七圖:不同化療藥物處理對於神經細胞數量之影響 Figure 7: Effect of different chemotherapy drugs on the number of nerve cells

第八圖:不同化療藥物處理對於突觸數量之影響 Figure 8: Effect of different chemotherapy drugs on the number of synapses

第九圖:不同化療藥物處理對於軸樹突長度之影響 Figure 9: Effect of different chemotherapy drugs on the length of axial dendrites

本發明之目的及其結構功能上的優點,將依據以下圖面所示之結構,配合具體實施例予以說明,俾使審查委員能對本發明有更深入且具體之瞭解。 The object of the present invention and its structural and functional advantages will be explained in conjunction with the specific embodiments according to the structure shown in the following drawings, so that the reviewing committee can have a more in-depth and specific understanding of the present invention.

首先,請參閱第一圖,本發明一種建立分析模組快速評估神經功能之方法,其包括下列步驟:步驟一(S1):利用一螢光顯微影像系統擷取一具有複數個螢光標定(包含Hoechst染劑以標記細胞核)之培養細胞以進行影像分析,其中培養細胞係包含神經細胞;步驟二(S2):依據細胞核之面積大小與螢光強弱,選取表現軸、樹突螢光標定的神經細胞,排除非神經細胞,並計算神經細胞體之面積大小,及軸突、樹突之長度與分支數目,以確認神經細胞之軸、樹突生長情形,其中軸、樹突螢光標定可選自微管相關蛋白2(MAP2)抗體或神經元類型Ⅲ β-微管蛋白(TUJ1),而突觸螢光標定係選自突觸蛋白(Synaptophysin)抗體或突觸後密度蛋白95(PSD95);以及步驟三(S3):根據步驟二之軸、樹突螢光標定範圍,計算神經細胞上突觸(synapse)螢光標定的數目,以確認神經細胞生長情形,藉以評估神經功能。其中,神經細胞示意圖如第二圖所示。 First, referring to the first figure, the method for establishing an analysis module for quickly evaluating nerve function includes the following steps: Step 1 (S1): using a fluorescence microscopic image system to capture a plurality of cursors The cultured cells (containing Hoechst stain to label the nucleus) for image analysis, wherein the cultured cell line contains nerve cells; Step 2 (S2): according to the size of the nucleus and the intensity of the fluorescence, select the expression axis, the dendritic cursor The nerve cells, exclude non-neuronal cells, and calculate the size of the nerve cell body, and the length of axons, dendrites and the number of branches to confirm the axis of the nerve cells, dendritic growth, where the axis, the dendritic It may be selected from a microtubule-associated protein 2 (MAP2) antibody or a neuronal type III β-tubulin (TUJ1), and the synaptophysin cursor is selected from a synaptophysin antibody or a post-synaptic density protein 95 ( PSD95); and step 3 (S3): According to the axis of step 2 and the range of the dendritic cursor, calculate the number of synapse cursors on the nerve cells to confirm the growth of the nerve cells. Assess nerve function. Among them, the schematic diagram of the nerve cells is shown in the second figure.

上述步驟一所述「培養細胞」可例如但不限定由下列步驟製得,步驟一:取一幼鼠(最佳為出生後0~1天之小鼠或大鼠)的大腦皮質組織,加入一第一培養基(可例如為不含血清之DMEM/F12培養基)打散大腦皮質組織,以形成一混合液;步驟二:過濾混合液,並以離心方式獲得一細胞沉 澱液;以及步驟三:將細胞沉澱液培養於一第二培養基(可例如包含Neurobasal® A培養基(Neurobasal® A medium)、L-麩醯胺酸(L-glutamin)、B-27®添加劑(B-27® Supplement),以及青黴素-鏈黴素(Penicillin/Streptomycin))內9~12天(最佳為10天),以製備出培養細胞。 The "culturing cells" described in the above step 1 can be prepared, for example, but not limited to, by the following steps: Step 1: Take the cerebral cortex tissue of a young mouse (best mouse or rat 0 to 1 day after birth), and add A first medium (for example, serum-free DMEM/F12 medium) is used to break up cerebral cortical tissue to form a mixed solution; Step 2: filtering the mixture and obtaining a cell pellet by centrifugation; and Step 3: The cell pellet is cultured in a second medium (for example, Neurobasal ® A medium (Neurobasal ® A medium), L-glutamin, B-27 ® Additive (B-27 ® Supplement), And 9 to 12 days (preferably 10 days) in penicillin-streptomycin to prepare cultured cells.

此外,藉由下述具體實施例,可進一步證明本發明可實際應用之範圍,但不意欲以任何形式限制本發明之範圍。 In addition, the scope of the invention may be further exemplified by the following specific examples, which are not intended to limit the scope of the invention.

實施例一:初代培養細胞並進行免疫螢光染色Example 1: Primary culture of cells and immunofluorescence staining

相較於傳統細胞株誘發分化的方法,藉由神經細胞初代培養之方法,更接近神經細胞的狀態,能評估早期神經網絡的形成,且實驗結果不受分化藥物影響,故本發明較佳係使用初代培養細胞。 Compared with the method of inducing differentiation of the traditional cell line, the method of the primary culture of the nerve cell is closer to the state of the nerve cell, and the formation of the early neural network can be evaluated, and the experimental result is not affected by the differentiation drug, so the present invention is better. Primary cells were cultured using the original.

(1)初代培養細胞 (1) Primary culture cells

採取出生後0~1天的小鼠(B6 mice pup)大腦皮質區(cortex),去除腦膜後利用不含血清的DMEM/F12培養基將組織打散,補足不含血清的DMEM/F12的體積至5mL,加入0.5mL 1X胰蛋白酶(trypsin)混勻,37℃水浴5分鐘,使用70μm過濾膜浸潤1mL胎牛血清(fetal bovine serum,FBS)將雜質進行過濾,離心3,000rpm 10分鐘,去除上清液,將沉澱下來的細胞加入須要量的培養基(培養基配製:Neurobasal® A medium 500mL,L-glutamin 100X 1.3mL,B-27® Supplement 50 X 10mL/vial,Penicillin/Streptomycin 100X 2.5mL),進行神經細胞培養。 The mouse cortex was taken from 0 to 1 day after birth (B6 mice pup). After removal of the meninges, the tissues were dispersed in serum-free DMEM/F12 medium to make up the volume of serum-free DMEM/F12. 5mL, add 0.5mL 1X trypsin (trypsin) to mix, water bath at 37 ° C for 5 minutes, use a 70μm filter membrane to infiltrate 1mL fetal bovine serum (FBS) to filter impurities, centrifuge 3,000rpm for 10 minutes, remove the supernatant To the solution, add the precipitated cells to the required amount of medium (medium preparation: Neurobasal ® A medium 500 mL, L-glutamin 100X 1.3 mL, B-27 ® Supplement 50 X 10 mL/vial, Penicillin/Streptomycin 100X 2.5 mL) for nerve Cell culture.

(2)使用透明薄底微量多孔黑盤進行神經細胞培養,培養前盤中每孔先加入70μL的多聚離胺酸(poly-D-lysine或poly-L-lysine)進行塗佈(coating)動作,再於每孔種2.8×104的細胞進行培養;體外培養7、10、 14、21天後,以4%聚甲醛(polyformaldehyde)固定細胞10分鐘,利用PBS沖洗5分鐘2次;加入1M甘胺酸(glycine)作用10分鐘,再利用PBS沖洗5分鐘2次;加入0.05% Triton X-100作用20分鐘,利用PBS沖洗5分鐘2次。接者,利用4%牛血清蛋白(BSA)阻斷(blocking)1小時之後,加入一級抗體:(1)微管相關蛋白2抗體(MAP2 antibody;MyBioSource;MBS502140)及(2)突觸蛋白抗體(Anti-Synaptophysin antibody;Abcam;ab32127)進行染色12~16小時;利用PBST沖洗10分鐘2次,並加入帶有螢光標定之二級抗體,分別為Alexa Fluor 488(Jackson ImmunoResearch;703-546-155)與Alexa Fluor 647(molecular probes;A31573),以及加入赫斯特染劑(Hoechst 33258)作用1小時,利用PBST沖洗10分鐘2次,最後加入PBS,並進行螢光影像擷取及分析。 (2) The nerve cells were cultured using a transparent thin-bottom microporous black disk, and 70 μL of poly-D-lysine or poly-L-lysine was added to each well in the culture plate for coating. The cells were cultured in 2.8×10 4 cells per well; after 7, 10, 14 and 21 days in vitro, the cells were fixed with 4% polyformaldehyde for 10 minutes, washed with PBS for 5 minutes twice; 1 M glycine was applied for 10 minutes, and then washed with PBS for 5 minutes twice; 0.05% Triton X-100 was added for 20 minutes, and washed with PBS for 5 minutes twice. Receiver, after blocking with 1% bovine serum albumin (BSA) for 1 hour, add primary antibody: (1) microtubule-associated protein 2 antibody (MAP2 antibody; MyBioSource; MBS502140) and (2) synaptic protein antibody (Anti-Synaptophysin antibody; Abcam; ab32127) for 12 to 16 hours; rinsed with PBST for 10 minutes twice, and added secondary antibody with a fluorescent cursor, respectively Alexa Fluor 488 (Jackson ImmunoResearch; 703-546- 155) and Alexa Fluor 647 (molecular probes; A31573), and adding Hurst dye (Hoechst 33258) for 1 hour, rinsing with PBST for 10 minutes 2 times, finally adding PBS, and performing fluorescence image extraction and analysis.

實施例二:影像擷取及影像分析Embodiment 2: Image capture and image analysis

使用螢光顯微影像系統擷取影像並進行上述培養細胞之影像分析,使用螢光波長DAPI、FITC及Cy5共3種,拍照完自動存取影像以進行分析。 The image was taken using a fluorescence microscopic imaging system and image analysis of the above cultured cells was performed. Three kinds of fluorescent wavelengths DAPI, FITC, and Cy5 were used, and images were automatically taken for analysis.

為了準確分析神經功能,使用MetaXpress 3.1軟體(網址ftp://ftp.meta.moleculardevices.com/pub/uic/software/MX31R13/HelpDocs/MetaXpress/MetaXpress_3_1_Anaiysis_Guide.pdf),標題為『MetaXpress® Image Acquisition and Analysis Software(Analysis Guide)』中找到,該文獻在此全部以引用的方式併入本文中)設計一分析模組。根據下列最佳化的影像分析指標(a)~(c)組合共32個步驟,進行自動化分析。 For accurate analysis of neural function, use MetaXpress 3.1 software (website ftp://ftp.meta.moleculardevices.com/pub/uic/software/MX31R13/HelpDocs/MetaXpress/MetaXpress_3_1_Anaiysis_Guide.pdf) with the title "MetaXpress ® Image Acquisition and Analysis It is found in the Software (Analysis Guide), which is hereby incorporated by reference in its entirety in its entirety herein in its entire entire entire entire entire entire entire entire entire entire entire portion Automated analysis was performed according to the following optimized image analysis indicators (a) to (c) in a total of 32 steps.

(a)定義神經細胞 (a) defining nerve cells

由於培養細胞中包含神經細胞與神經膠質細胞(glialcell),因 此需先依據Hoechst染劑標示之細胞核面積大小與螢光強弱,搭配MAP2抗體以選取真正的神經細胞;可例如使用MetaXpress 3.1軟體中內建的選項依下述之順序進行設定16個步驟: Because cultured cells contain nerve cells and glial cells, This is based on the size of the nuclear area indicated by the Hoechst stain and the intensity of the fluorescence, with the MAP2 antibody to select the true nerve cells; for example, the built-in options in the MetaXpress 3.1 software can be set in 16 steps in the following order:

1:Configure Count Nuclei Data Log() 1: Configure Count Nuclei Data Log()

2:Configure Count Nuclei Summary Log() 2: Configure Count Nuclei Summary Log()

3:Overwrite "Nuclear_All"=Count Nuclei(Src="DAPI") 3: Overwrite "Nuclear_All"=Count Nuclei(Src="DAPI")

4:Threshold Image([3:Count Nuclei],1,65535,Inclusive) 4: Threshold Image ([3: Count Nuclei], 1, 65535, Inclusive)

5:Create Regions Around Objects([3:Count Nuclei]) 5: Create Regions Around Objects([3:Count Nuclei])

6:Transfer Regions([3:Count Nuclei],"DAPI",ALLREGIONS and CLEARSOURCE and CLEARDEST) 6: Transfer Regions([3:Count Nuclei],"DAPI",ALLREGIONS and CLEARSOURCE and CLEARDEST)

7:Preferences() 7: Preferences()

8:Threshold Image["DAPI",1,65535,Inclusive] 8: Threshold Image["DAPI",1,65535,Inclusive]

9:Integrated Morphometry-Load State("NeuriteNuclear test") 9: Integrated Morphometry-Load State("NeuriteNuclear test")

10:Integrated Morphometry-Measure("DAPI") 10: Integrated Morphometry-Measure("DAPI")

11:Integrated Morphometry-Create Objects Mask() 11: Integrated Morphometry-Create Objects Mask()

12:Untitled=New(1392,1040,16,0) 12: Untitled=New(1392,1040,16,0)

13:Overwrite "Nuclear_IMA"=[12:New]+"IMA Objects Mask" 13: Overwrite "Nuclear_IMA"=[12:New]+"IMA Objects Mask"

14:Configure Neurite Outgrowth Data Log() 14: Configure Neurite Outgrowth Data Log()

15:Configure Neurite Outgrowth Summary Log() 15: Configure Neurite Outgrowth Summary Log()

16:[None]=Neurite Outgrowth(NeuriteSrc="FITC",NuclearSrc=[13:Arithmetic],NuclearDest=Overwrite"Nuclear_Neurite")。 16:[None]=Neurite Outgrowth(NeuriteSrc="FITC",NuclearSrc=[13:Arithmetic],NuclearDest=Overwrite"Nuclear_Neurite").

藉此,先將影像中所有細胞核全算入,再將所有細胞核依面積大小與螢光強弱區分,並區分細胞核與神經細胞標記MAP2有螢光重疊的細胞核,得到真正的神經細胞。 In this way, all the nuclei in the image are first counted, and then all the nuclei are distinguished from the fluorescence intensity by the size of the cell, and the nuclei of the cell and the neuronal cell marker MAP2 are overlapped to obtain true nerve cells.

(b)分析神經細胞之軸、樹突生長情形 (b) Analysis of the axis and dendritic growth of nerve cells

選取表現微管相關蛋白2(MAP2)的神經細胞之後,計算神經細胞體之面積大小,及軸突、樹突之長度與分支數目,以確認神經細胞之軸、樹突生長情形;可例如使用MetaXpress 3.1軟體中內建的選項依下述之順序進行設定6個步驟: After selecting the nerve cells expressing microtubule-associated protein 2 (MAP2), calculate the size of the nerve cell body, and the length of axons, dendrites and the number of branches to confirm the axis and dendritic growth of the nerve cells; The built-in options in MetaXpress 3.1 software are set in 6 steps in the following order:

17:Threshold Image([16:Neurite Outgrowth],1,65535,Inclusive) 17: Threshold Image([16:Neurite Outgrowth], 1,65535, Inclusive)

18:Overwrite "NeuriteNuclear_Binary"=Clip Image(16,[16:Neurite Outgrowth]) 18: Overwrite "NeuriteNuclear_Binary"=Clip Image(16,[16:Neurite Outgrowth])

19:Overwrite "Add"="FITC"+[18:Clip Image] 19: Overwrite "Add"="FITC"+[18:Clip Image]

20:Configure Neurite Outgrowth Data Log() 20: Configure Neurite Outgrowth Data Log()

21:Configure Neurite Outgrowth Summary Log() 21: Configure Neurite Outgrowth Summary Log()

22:Overwrite "Neurite"=Neurite Outgrowth(NeuriteSrc=[19:Arithmetic],NuclearSrc=[None],NuclearDest=[None]) 22: Overwrite "Neurite"=Neurite Outgrowth(NeuriteSrc=[19:Arithmetic],NuclearSrc=[None],NuclearDest=[None])

藉此,可分析神經細胞體範圍與自神經細胞延伸出來的軸、 樹突長度及分支數目。 Thereby, the range of the nerve cell body and the axis extending from the nerve cell can be analyzed, Density length and number of branches.

(c)分析神經細胞突觸生長情形 (c) Analysis of synaptic growth in nerve cells

根據上述軸、樹突螢光標定範圍,計算表現突觸蛋白(Synaptophysin)的突觸(synapse)數目,以確認神經細胞生長情形;可例如使用MetaXpress 3.1軟體中內建的選項依下述之順序進行設定10個步驟: Calculate the number of synapse that express Synaptophysin according to the above-mentioned range of axis and dendritic cursors to confirm the growth of nerve cells; for example, the options built into MetaXpress 3.1 software can be used in the following order. Set 10 steps:

23:Configure Cell Scoring Data Log() 23: Configure Cell Scoring Data Log()

24:Configure Cell Scoring Summary Log() 24: Configure Cell Scoring Summary Log()

25:Overwrite "NeuronBinary"=Cell Scoring(All nuclei=[18:Clip Image],Positive marker="FITC") 25: Overwrite "NeuronBinary"=Cell Scoring(All nuclei=[18:Clip Image],Positive marker="FITC")

26:Threshold Image([25:Cell Scoring],1,65535,Inclusive) 26: Threshold Image ([25: Cell Scoring], 1, 65535, Inclusive)

27:Overwrite "Binary"=Binarize([25:Cell Scoring]),1,65535 27: Overwrite "Binary"=Binarize([25:Cell Scoring]),1,65535

28:Overwrite "AND"="Cy5" AND[27:Binary Operations] 28: Overwrite "AND"="Cy5" AND[27:Binary Operations]

29:Configure Transfluor Data Log() 29: Configure Transfluor Data Log()

30:Configure Transfluor Summary Log() 30: Configure Transfluor Summary Log()

31:[None]=Transfluor(Pit/Vesicle Source=[28:Arithmetic],Nuclear Source=[18:Clip Image]) 31: [None]=Transfluor(Pit/Vesicle Source=[28:Arithmetic],Nuclear Source=[18:Clip Image])

32:Close All(NOQUERY) 32: Close All (NOQUERY)

藉此,將神經細胞體及微管相關蛋白2(MAP2)標示的範圍算入,可得到神經細胞範圍內所含的突觸(synapse)數量。 Thereby, the range of the nerve cell body and the microtubule-associated protein 2 (MAP2) is counted, and the number of synapse contained in the range of the nerve cell can be obtained.

藉由上述32個步驟,得以了解神經生長與神經網絡形成的情形;舉例而言,利用此模組進行分析,1孔3種螢光標定197個視野共591張影像,僅需2小時就能得到完整的結果。 Through the above 32 steps, you can understand the situation of nerve growth and neural network formation; for example, using this module for analysis, 1 hole and 3 kinds of fire cursors set 197 views with 591 images, only 2 hours Get the full result.

請參閱第三圖,為小鼠大腦皮質神經細胞於體外(in vitro)培養7、10、14及21天(7~21 DIV)之代表圖,綠色標示處代表神經細胞體和樹突(anti-MAP2)、紅色標示處代表前突觸(anti-synaptophysin),藍色標示處代表細胞核(Hoechst);圖中的比例尺長度為50μm。 Please refer to the third figure for representative images of mouse cerebral cortical neurons cultured in vitro for 7, 10, 14 and 21 days (7~21 DIV). The green markers represent neuronal cell bodies and dendrites (anti- MAP2), the red mark represents the anti-synaptophysin, and the blue mark represents the nucleus (Hoechst); the scale length in the figure is 50 μm.

進一步利用如上述32個步驟進行分析,得到初代培養細胞之實驗結果如第四圖~第六圖。檢視第四圖,正常神經細胞在不同培養天數測得的神經細胞數量以培養10天最佳;檢視第五圖,主分之長度、軸樹突長度及小分支數量雖然於培養14天最佳,但第六圖顯示,突觸數量亦如第四圖在培養10天最佳,培養14天突觸數量下降;故,在快速取得神經細胞以進行後續分析的前提下,選擇培養天數10天為最佳條件。 Further, using the above 32 steps for analysis, the experimental results of the primary cultured cells are as shown in the fourth to sixth figures. Looking at the fourth picture, the number of nerve cells measured by normal nerve cells in different culture days is best for 10 days; the fifth picture, the length of the main points, the length of the axis dendrites and the number of small branches are best in 14 days of culture. However, the sixth figure shows that the number of synapses is also the best in the 10th day of culture as shown in the fourth figure, and the number of synapses in the 14th day of culture is decreased; therefore, the number of culture days is 10 days after the rapid acquisition of nerve cells for subsequent analysis. For the best conditions.

實施例三:檢測化療藥物對於神經細胞的影響Example 3: Detecting the effect of chemotherapeutic drugs on nerve cells

(1)初代培養細胞 (1) Primary culture cells

採取出生後0~1天的小鼠(B6 mice pup)大腦皮質區(cortex),去除腦膜後利用不含血清的DMEM/F12培養基將組織打散,補足不含血清的DMEM/F12的體積至5mL,加入0.5mL 1X胰蛋白酶(trypsin)混勻,37℃水浴5分鐘,使用70μm過濾膜浸潤1mL胎牛血清(fetal bovine serum,FBS)將雜質進行過濾,離心3,000rpm 10分鐘,去除上清液,將沉澱下來的細胞加入須要量的培養基(培養基配製:Neurobasal® A medium 500mL,L-glutamin 100X 1.3mL,B-27® Supplement 50 X 10mL/vial, Penicillin/Streptomycin 100X 2.5mL),進行神經細胞培養。 The mouse cortex was taken from 0 to 1 day after birth (B6 mice pup). After removal of the meninges, the tissues were dispersed in serum-free DMEM/F12 medium to make up the volume of serum-free DMEM/F12. 5mL, add 0.5mL 1X trypsin (trypsin) to mix, water bath at 37 ° C for 5 minutes, use a 70μm filter membrane to infiltrate 1mL fetal bovine serum (FBS) to filter impurities, centrifuge 3,000rpm for 10 minutes, remove the supernatant To the solution, add the precipitated cells to the required amount of medium (medium preparation: Neurobasal ® A medium 500 mL, L-glutamin 100X 1.3 mL, B-27 ® Supplement 50 X 10 mL/vial, Penicillin/Streptomycin 100X 2.5 mL) for nerve Cell culture.

(2)使用透明薄底微量多孔黑盤進行神經細胞培養,培養前盤中每孔先加入70μL的多聚離胺酸(poly-D-lysine或poly-L-lysine)進行塗佈(coating)動作,再於每孔種2.8×104的細胞進行培養;體外培養10天之後,加入如表一之化療藥物於細胞作用24小時,以4%聚甲醛(polyformaldehyde)固定細胞10分鐘,利用PBS沖洗5分鐘2次;加入1M甘胺酸(glycine)作用10分鐘,再利用PBS沖洗5分鐘2次;加入0.05% Triton X-100作用20分鐘,利用PBS沖洗5分鐘2次。利用4%牛血清蛋白(BSA)阻斷(blocking)1小時,加入一級抗體:(1)微管相關蛋白2抗體(MAP2 antibody;MyBioSource;MBS502140)及(2)突觸蛋白抗體(Anti-Synaptophysin antibody;Abcam;ab32127)進行染色12~16小時;利用PBST沖洗10分鐘2次,並加入帶有螢光標定之二級抗體,分別為Alexa Fluor 488(Jackson ImmunoResearch;703-546-155)與Alexa Fluor 647(molecular probes;A31573),以及加入赫斯特染劑(Hoechst 33258)作用1小時,利用PBST沖洗10分鐘2次,最後加入PBS,並進行螢光影像擷取及分析。 (2) The nerve cells were cultured using a transparent thin-bottom microporous black disk, and 70 μL of poly-D-lysine or poly-L-lysine was added to each well in the culture plate for coating. The cells were cultured in 2.8×10 4 cells per well; after 10 days of in vitro culture, the chemotherapeutic drugs as shown in Table 1 were added to the cells for 24 hours, and the cells were fixed with 4% polyformaldehyde for 10 minutes, using PBS. Rinse twice for 5 minutes; add 1 M glycine for 10 minutes, rinse with PBS for 5 minutes twice; add 0.05% Triton X-100 for 20 minutes, rinse with PBS for 5 minutes twice. Primary antibody was blocked by blocking with 4% bovine serum albumin (BSA) for 1 hour: (1) microtubule-associated protein 2 antibody (MAP2 antibody; MyBioSource; MBS502140) and (2) synaptic protein antibody (Anti-Synaptophysin) Antibody; Abcam; ab32127) staining for 12-16 hours; rinsing with PBST for 10 minutes twice, and adding secondary antibodies with a fluorescent cursor, Alexa Fluor 488 (Jackson ImmunoResearch; 703-546-155) and Alexa Fluor 647 (molecular probes; A31573), and Hurst dye (Hoechst 33258) were added for 1 hour, washed with PBST for 10 minutes twice, finally added with PBS, and subjected to fluorescence image extraction and analysis.

(3)使用如實施例二之螢光顯微影像系統及方法,擷取影像以進行上述培養細胞之影像分析,影像呈現放大200倍(200X),使用螢光波長DAPI、FITC及Cy5共3種,拍照完自動存取影像以進行分析。 (3) Using the fluorescence microscopic imaging system and method as in the second embodiment, capturing images for image analysis of the cultured cells, the image is magnified 200 times (200X), using fluorescent wavelengths DAPI, FITC, and Cy5 3 Kindly, the image is automatically accessed after the photo is taken for analysis.

請參閱第七圖~第九圖,分別代表不同化療藥物處理對於神經細胞數量、突觸數量及軸樹突長度之影響,各組皆與未投藥控制組相比較(相對控制組%)。由結果可知,長春新鹼Vincristine具有明顯的神經細胞毒性(neurotoxicity);與順鉑Cisplatin相比,佳鉑帝Carboplatin具有較低神經細胞毒性;而拓樸異構酶抑制劑(Topoisomerase inhibitor)包括艾黴素Doxorubicin與微脂體艾黴素(Lipo-Dox®),以及核苷類似物(nucleoside analogue)吉西他濱Gemcitabine的神經細胞毒性較低。 Please refer to the seventh to ninth figures, respectively, for the effects of different chemotherapeutic drugs on the number of nerve cells, the number of synapses and the length of the axial dendrites, respectively, compared with the non-administered control group (relative control group%). From the results, vincristine has obvious neurotoxicity; compared with cisplatin Cisplatin, Carboplatin has lower neurocytotoxicity; and Topoisomerase inhibitor includes Ai The neurotoxicity of the doxorubicin and the liposome erythromycin (Lipo-Dox ® ), as well as the nucleoside analogue gemcitabine, is lower.

由於細胞培養及影像擷取之後,搭配使用高通量分析系統並利用本發明最佳化模組(32個步驟)分析神經細胞功能,可快速得到各種分析結果。本方法不僅可應用於任何神經相關的藥物篩選與檢測,例如藥物對神經系統的毒性或保護效果,亦可用於學術界探討神經系統功能與訊息傳遞之標的分子的探尋。 After cell culture and image capture, a variety of analytical results can be quickly obtained by using a high-throughput analysis system and using the optimized module of the present invention (32 steps) to analyze nerve cell function. The method can be applied not only to the screening and detection of any nerve-related drugs, such as the toxicity or protection effect of drugs on the nervous system, but also the exploration of the molecules of the nervous system function and message transmission in the academic circle.

由上述之實施說明可知,本發明與現有技術相較之下,本發明具有以下優點: It can be seen from the above description that the present invention has the following advantages compared with the prior art:

1. 本發明經過反覆驗證,篩選出幾個代表性的分子標記做為評估早期神經生長與神經網絡的形成,相較於目前以評估神經細胞存活 狀況為主的方法,更能確切偵測神經功能的變化。 1. The present invention has been repeatedly verified to screen out several representative molecular markers for assessing early nerve growth and neural network formation, as compared to current assessment of neuronal survival. The situation-based approach is more accurate in detecting changes in neurological function.

2. 本發明以影像與型態為基礎的分析方法,將神經細胞生長與幾項重要指標設計成一完整的功能評估模組,並排除不具鑑別力的指標,在省時、大量與完整評估之間取得良好平衡,故可應用於任何神經相關藥物的高通量篩選與檢測中,以快速及準確地評估藥物對神經系統的作用。 2. The image-and-type analysis method of the present invention designs neural cell growth and several important indicators into a complete functional evaluation module, and excludes non-discriminating indicators, in time-saving, large-scale and complete evaluation. A good balance between the two, so it can be applied to high-throughput screening and detection of any nerve-related drugs to quickly and accurately assess the effects of drugs on the nervous system.

綜上所述,本發明之建立分析模組快速評估神經功能之方法,的確能藉由上述所揭露之實施例,達到所預期之使用功效,且本發明亦未曾公開於申請前,誠已完全符合專利法之規定與要求。爰依法提出發明專利之申請,懇請惠予審查,並賜准專利,則實感德便。 In summary, the method for establishing a rapid analysis of neural function by the analysis module of the present invention can achieve the intended use efficiency by the above disclosed embodiments, and the present invention has not been disclosed before the application, and has been completely completed. Meet the requirements and requirements of the Patent Law.爰Issuing an application for a patent for invention in accordance with the law, and asking for a review, and granting a patent, is truly sensible.

惟,上述所揭之圖示及說明,僅為本發明之較佳實施例,非為限定本發明之保護範圍;大凡熟悉該項技藝之人士,其所依本發明之特徵範疇,所作之其它等效變化或修飾,皆應視為不脫離本發明之設計範疇。 The illustrations and descriptions of the present invention are merely preferred embodiments of the present invention, and are not intended to limit the scope of the present invention; those skilled in the art, which are characterized by the scope of the present invention, Equivalent variations or modifications are considered to be within the scope of the design of the invention.

(S1)‧‧‧步驟一 (S1)‧‧‧Step one

(S2)‧‧‧步驟二 (S2)‧‧‧Step 2

(S3)‧‧‧步驟三 (S3) ‧ ‧ Step 3

Claims (3)

一種建立分析模組快速評估神經功能之方法,其包括下列步驟:步驟一:利用一螢光顯微影像系統擷取一具有複數個螢光標定之培養細胞以進行該培養細胞之影像分析,其中該螢光顯微影像系統係內建有一包含複數指令之分析模組依序執行該步驟一至步驟三,該培養細胞係包含神經細胞,該複數個螢光標定係包含赫斯特(Hoechst)染劑以標記細胞核;步驟二:依據細胞核之面積大小與螢光強弱,選取表現軸、樹突螢光標定的神經細胞,排除非神經細胞,並計算神經細胞體之面積大小,及軸突、樹突之長度與分支數目,以確認該神經細胞之軸、樹突生長情形,其中該軸、樹突螢光標定係選自微管相關蛋白2(MAP2)抗體或神經元類型Ⅲ β-微管蛋白(TUJ1);以及步驟三:根據該步驟二之軸、樹突螢光標定範圍,計算該神經細胞上突觸(synapse)螢光標定的數目,以確認該神經細胞生長情形,藉以評估神經功能,其中該突觸螢光標定係選自突觸蛋白(Synaptophysin)抗體或突觸 後密度蛋白95(PSD95)。 A method for establishing an analysis module for rapid assessment of neural function includes the following steps: Step 1: Using a fluorescence microscopic imaging system to capture a cultured cell having a plurality of fluorescing cursors for image analysis of the cultured cells, wherein The fluorescence microscopic imaging system is internally provided with an analysis module including a plurality of instructions, which sequentially perform the steps 1 to 3. The culture cell line comprises nerve cells, and the plurality of fluorescent cursors comprise Hoechst dyeing. The agent is used to label the nucleus; Step 2: According to the size of the nucleus and the intensity of the fluorescein, the nerve cells of the expression axis and the dendritic fluorescein are selected, the non-neuronal cells are excluded, and the area of the nerve cell body is calculated, and the axon and the tree are calculated. The length of the protrusion and the number of branches to confirm the axis of the nerve cell and the growth of the dendrites, wherein the axis, the dendritic cursor is selected from the group consisting of microtubule-associated protein 2 (MAP2) antibody or neuron type III β-microtube Protein (TUJ1); and step three: according to the axis of the second step, the threshold of the dendritic cursor, calculate the number of synapse cursors on the nerve cells, to determine The case nerve cell growth, thereby neurological assessment, which is selected from the synapse fluorescence calibration synapsin (of Synaptophysin) antibody or synapse Post-density protein 95 (PSD95). 如申請專利範圍第1項所述之建立分析模組快速評估神經功能之方法,其中該培養細胞係由下列步驟製得:步驟一:將源自一幼鼠大腦皮質組織之細胞加入一第一培養基打散以形成一混合液,其中幼鼠係出生後0~1天之小鼠(mouse)或大鼠(rat),且該第一培養基係不含血清之DMEM/F12培養基;步驟二:過濾該混合液,並以離心方式獲得一細胞沉澱液;以及步驟三:將該細胞沉澱液培養於一第二培養基內9~12天,以製備出該培養細胞,其中該第二培養基係包含Neurobasal® A培養基(Neurobasal® A medium)、L-麩醯胺酸(L-glutamin)、B-27®添加劑(B-27® Supplement),以及青黴素-鏈黴素(Penicillin/Streptomycin)。 The method for rapidly evaluating nerve function by establishing an analysis module as described in claim 1, wherein the cultured cell line is obtained by the following steps: Step 1: adding cells derived from the cerebral cortex tissue of a young rat to the first The medium is broken up to form a mixed solution, wherein the young mouse is a mouse or a rat of 0 to 1 day after birth, and the first medium is a serum-free DMEM/F12 medium; Step 2: Filtering the mixture and obtaining a cell pellet by centrifugation; and Step 3: culturing the cell pellet in a second medium for 9 to 12 days to prepare the cultured cells, wherein the second medium comprises Neurobasal ® A medium (Neurobasal ® A medium), L- Glutamic acid amide (L-glutamin), B- 27 ® additive (B-27 ® Supplement), and penicillin - streptomycin (penicillin / streptomycin). 如申請專利範圍第2項所述之建立分析模組快速評估神經功能之方法,其中係將該細胞沉澱液培養於該第二培養基內10天,以製備出該培養細胞。 A method for rapidly evaluating nerve function by establishing an analysis module as described in claim 2, wherein the cell pellet is cultured in the second medium for 10 days to prepare the cultured cell.
TW103133108A 2014-09-24 2014-09-24 Method for quick evaluating neural function by establishing analysis module TWI548873B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW103133108A TWI548873B (en) 2014-09-24 2014-09-24 Method for quick evaluating neural function by establishing analysis module

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW103133108A TWI548873B (en) 2014-09-24 2014-09-24 Method for quick evaluating neural function by establishing analysis module

Publications (2)

Publication Number Publication Date
TW201612523A TW201612523A (en) 2016-04-01
TWI548873B true TWI548873B (en) 2016-09-11

Family

ID=56360840

Family Applications (1)

Application Number Title Priority Date Filing Date
TW103133108A TWI548873B (en) 2014-09-24 2014-09-24 Method for quick evaluating neural function by establishing analysis module

Country Status (1)

Country Link
TW (1) TWI548873B (en)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
2014年03月14日,High Content Image Analysis Identifies Novel Regulators of Synaptogenesis in a High-Throughput RNAi Screen of Primary Neurons,PLoS One. 2014 Mar 14;9(3):e91744 2011年03月04日,年齡對交感神經節節後神經細胞之細胞核大小的影響,劉增容,美和科技大學 2010年07月15日,A computational framework for studying neuron morphology from in vitro high content neuron-based screening, J Neurosci Methods. 2010 Jul 15;190(2):299-309. 1992年05月,Demonstration of local protein synthesis within dendrites using a new cell culture system that permits the isolation of living axons and dendrites from their cell bodies,J Neurosci. 1992 Mar;12(3):762-72. *

Also Published As

Publication number Publication date
TW201612523A (en) 2016-04-01

Similar Documents

Publication Publication Date Title
Sun et al. A whole-brain map of long-range inputs to GABAergic interneurons in the mouse medial prefrontal cortex
Paşca et al. Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture
Vergara et al. Three-dimensional automated reporter quantification (3D-ARQ) technology enables quantitative screening in retinal organoids
Micheva et al. Single-synapse analysis of a diverse synapse population: proteomic imaging methods and markers
Hansen et al. Neurogenic radial glia in the outer subventricular zone of human neocortex
Harrill et al. Ontogeny of biochemical, morphological and functional parameters of synaptogenesis in primary cultures of rat hippocampal and cortical neurons
Little et al. A single cell high content assay detects mitochondrial dysfunction in iPSC-derived neurons with mutations in SNCA
Verstraelen et al. Image-based profiling of synaptic connectivity in primary neuronal cell culture
Sisnaiske et al. Acrylamide alters neurotransmitter induced calcium responses in murine ESC-derived and primary neurons
CN104931473B (en) It is a kind of to determine the evaluation method that soluble heavy metal causes DNA Damage
D’Aiuto et al. Generation of three-dimensional human neuronal cultures: application to modeling CNS viral infections
Sandström et al. Development and characterization of a human embryonic stem cell-derived 3D neural tissue model for neurotoxicity testing
WO2018183446A1 (en) Assembly of functionally integrated human forebrain spheroids and methods of use thereof
Filby et al. The analysis of cell cycle, proliferation, and asymmetric cell division by imaging flow cytometry
Strong et al. Functional brain region-specific neural spheroids for modeling neurological diseases and therapeutics screening
Radio Neurite outgrowth assessment using high content analysis methodology
CN105985999B (en) Method for creating an analysis module for assessing neurological function
Birtele et al. Single-cell transcriptional and functional analysis of dopaminergic neurons in organoid-like cultures derived from human fetal midbrain
Sadick et al. Protein characterization of intracellular target-sorted, formalin-fixed cell subpopulations
de Groot et al. Characterization of calcium responses and electrical activity in differentiating mouse neural progenitor cells in vitro
Leao et al. A voltage-sensitive dye-based assay for the identification of differentiated neurons derived from embryonic neural stem cell cultures
TWI548873B (en) Method for quick evaluating neural function by establishing analysis module
US10520493B2 (en) Method for assessment of neural function by establishing analysis module
Chitsaz et al. An automated strategy for unbiased morphometric analyses and classifications of growth cones in vitro
Fedr et al. Variability of fluorescence intensity distribution measured by flow cytometry is influenced by cell size and cell cycle progression